PURE

PURE Bioscience

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 12/15/2016
Contact Info
  • 1725 Gillespie Way
  • El Cajon, CA 92020

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jan 31, 2017 10-Q
CIK 0001006028
Fiscal Year End 7/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2890 - Miscellaneous Chemical Products
Incorporated In: DE, USA
Year of Inc. 1992
Employees 13 a/o Oct 24, 2013
Company Officers/Contacts
Henry Lambert CEO
Mark Elliott VP, Fin., Principal Fin. Officer, Principal Acct. Officer
Company Directors
David Pfanzelter Chairman
Gary D. Cohee
Tom Y. Lee
William Otis
David Theno
Service Providers
Accounting/Auditing Firm
Mayer Hoffman McCann P.C.
10616 Scripps Summit Court
San Diego, CA, 92131
United States
 
Securities Counsel
DLA Piper LLP
4365 Executive Drive
Suite 1100
San Diego, CA, 92101-4297
United States
 
Investor Relations Firm
Bibicoff & MacInnis, Inc.
18801 Ventura Blvd.
Suite 312
Tarzana, CA, 91356
United States
 
Company History
  • Formerly=Innovative Medical Services until 10-03
PURE Security Details
Share Structure
Market Value1 $57,552,485 a/o Mar 28, 2017
Authorized Shares 100,000,000 a/o Mar 08, 2017
Outstanding Shares 62,557,049 a/o Mar 08, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
Transfer Online, Inc.
Shareholders
Shareholders of Record 227 a/o Oct 27, 2016
Short Selling Data
Short Interest 206,530 (194.24%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security